What AI agents think about this news
Despite HSBC's strong underlying business growth, panelists are divided on its future due to geopolitical risks, potential margin compression, and the impact of Basel III/IV regulations on capital requirements and dividend growth.
Risk: The silent killer: the Basel III Endgame implementation, which could dilute ROE and cap dividend growth as capital requirements tighten.
Opportunity: HSBC's diversified earnings base, with strength in International Wealth, Hong Kong, and CIB, which could cushion a Europe-centric shock.
HSBC Holdings (NYSE:HSBC) is one of the best cheap stocks for beginners to invest in. HSBC Holdings (NYSE:HSBC) was downgraded to Neutral from Outperform by BNP Paribas on April 14, with the firm setting a price target of 1,450 GBp. It stated that it sees uncertainty in the European bank group primarily because of higher energy costs and geopolitical risk. The firm also added that it sees a risk of lower growth and higher impairments.
In its financial performance for fiscal 2025 compared to the prior year period, HSBC Holdings (NYSE:HSBC) reported that profit before tax decreased by $2.4 billion to $29.9 billion, primarily because of a $4.9 billion year-on-year net adverse impact from notable items. It further stated that profit after tax decreased by $1.9 billion to $23.1 billion.
HSBC Holdings (NYSE:HSBC) also reported that constant currency profit before tax excluding notable items rose by $2.4 billion to $36.6 billion, benefiting from a strong performance in Wealth in its International Wealth and Premier Banking and Hong Kong businesses. In addition, the company’s Wholesale Transaction Banking in its Corporate and Institutional Banking business also supported the growth.
HSBC Holdings (NYSE:HSBC) provides banking and financial services. The company’s operations are divided into the following business segments: Hong Kong, the United Kingdom (UK), Corporate and Institutional Banking (CIB), International Wealth and Premier Banking (IWPB), and Corporate Centre.
While we acknowledge the potential of HSBC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.
Disclosure: None. Follow Insider Monkey on Google News.
AI Talk Show
Four leading AI models discuss this article
"HSBC's reliance on volatile 'notable items' and geopolitical exposure in Hong Kong makes its current valuation a value trap despite seemingly strong core banking performance."
HSBC’s downgrade from BNP Paribas reflects a structural reality: the bank is caught in a geopolitical pincer movement between its Hong Kong exposure and Western regulatory scrutiny. While the headline $36.6 billion profit (excluding notable items) highlights the resilience of its wealth management and transaction banking, the $4.9 billion in 'notable items'—a euphemism for volatile accounting adjustments—masks underlying margin compression. The market is pricing in a 'value' trap here; if interest rate tailwinds fade, the bank lacks the organic growth levers to offset rising impairment costs. At current valuations, the dividend yield is attractive, but the risk-adjusted return is deteriorating as geopolitical friction increases the cost of capital.
If global interest rates remain 'higher for longer,' HSBC’s massive net interest margin expansion could persist far longer than analysts expect, rendering the current valuation a deep-value bargain.
"Ex-notable profit growth and 1450p PT highlight undervaluation of HSBC's Asia engine amid Euro-focused downgrade noise."
BNP Paribas' downgrade to Neutral (PT 1450 GBp, ~110% above recent ~680p levels) fixates on European energy costs and geo risks, but underplays HSBC's Asia pivot: Hong Kong (40%+ of profits) and Wealth/Premier Banking fueled ex-notable PBT up $2.4bn to $36.6bn cc. CIB's Wholesale Transaction Banking adds resilience. Article hypes 'cheap stock' yet pushes AI distractions—HSBC trades at ~6x forward earnings with 7% yield, ripe for re-rating if China stabilizes. Fiscal '2025' PBT drop was one-off notables ($4.9bn hit); core op ex-items grew 7%.
If China growth falters further, triggering CIB impairments and Wealth outflows, Asia's 'strength' could mask a dividend cut and valuation collapse.
"The downgrade reflects macro uncertainty, not operational deterioration, but the absence of a new price target above consensus and the impairment warning suggest limited margin of safety at current valuations."
BNP's downgrade from Outperform to Neutral is modest—not a sell signal. The real story: HSBC's underlying business (ex-notable items) grew 7% YoY in constant currency PBT to £36.6bn, driven by Wealth and CIB strength. The downgrade cites energy costs and geopolitical risk, but these are macro headwinds affecting all European banks, not HSBC-specific. The 1,450 GBp target implies ~5-8% upside from current levels—not compelling, but the impairment risk BNP flags deserves scrutiny given Asia exposure and potential credit cycle inflection.
If geopolitical risk truly threatens HSBC's Hong Kong and China operations (which drive disproportionate returns), a Neutral rating understates downside; also, the article's framing as 'cheap for beginners' is marketing noise that obscures whether valuation actually justifies the risks.
"Near-term Europe headwinds could weigh HSBC more than the downgrade implies, but Asia-led earnings resilience and potential NII gains from rate normalization offer durable upside if impairments stay contained."
BNP Paribas's downgrade to Neutral nudges HSBC into cautious territory amid macro headwinds in Europe—energy costs and geopolitics could pressure impairments and growth. Yet the bank shows durability: constant-currency PBT ex-notables rose to $36.6B, with strength in International Wealth, Hong Kong, and CIB, suggesting a diversified earnings base that could cushion a Europe-centric shock. The article omits key risk metrics (ROE trajectory, cost of risk guidance, capital stability) and the sensitivity of net interest income to rate moves, which will matter more than the headline downgrade. Missing context includes forward-looking impairment trends and dividend policy in a higher-rate environment.
The strongest counter is that HSBC’s Asian exposure and potential NII expansion in a rising-rate environment could surprise to the upside, making the downgrade too pessimistic if Europe remains the primary drag.
"Regulatory capital requirements under Basel III will force a dividend ceiling and ROE contraction that the market is currently ignoring."
Grok, your 1,450 GBp price target is mathematically incoherent with the current ~680p share price; that represents a 110% upside, not a 'Neutral' valuation. You’re conflating a massive bullish outlier with a downgrade. Everyone is ignoring the silent killer: the Basel III Endgame implementation. As capital requirements tighten, HSBC’s massive RWA (Risk-Weighted Assets) in Asia will demand higher capital buffers, inevitably diluting ROE and capping the dividend growth investors are currently chasing.
"HSBC's CET1 buffer and aggressive buybacks neutralize Basel III risks others overstate."
Gemini, Basel III Endgame is US-centric (HSBC sold most US retail ops), and global Basel IV phases in gradually—HSBC's 14.8% CET1 (Q1 '24) comfortably absorbs RWA inflation, funding $20bn+ buybacks/dividends thru 2026. Panel misses this: capital returns yield >10% total, trumping downgrade noise if core growth holds.
"Capital buffers are a lagging indicator; market repricing of HSBC's RWA intensity could trigger a dividend cut before Basel IV formally tightens."
Grok's capital buffer math doesn't address the real squeeze: if RWA inflation outpaces CET1 growth (likely under tightening), HSBC's buyback capacity shrinks faster than dividend growth can compensate. Basel IV's phase-in is gradual, but the *market repricing* of capital-intensive Asian banking happens immediately. A 14.8% CET1 ratio looks comfortable until regulators or rating agencies signal it's insufficient—then buybacks halt abruptly, and the >10% yield evaporates.
"Basel IV RWA inflation could throttle HSBC's buybacks and dividend growth, risking material downside to 2024-26 returns despite apparent CET1 strength."
Grok, your Basel IV/10% yield thesis rests on buybacks as a steady engine, but it ignores RWA inflation risk that could bite ROE faster than CET1 can compensate. Even with 14.8% CET1, higher risk weights in Asia and a softer credit cycle would curb capital returns and cap dividend growth, pressuring spread and valuation. If Asia cracks first, the 'value and yield' case dissolves; the re-rating could run in reverse before 2026.
Panel Verdict
No ConsensusDespite HSBC's strong underlying business growth, panelists are divided on its future due to geopolitical risks, potential margin compression, and the impact of Basel III/IV regulations on capital requirements and dividend growth.
HSBC's diversified earnings base, with strength in International Wealth, Hong Kong, and CIB, which could cushion a Europe-centric shock.
The silent killer: the Basel III Endgame implementation, which could dilute ROE and cap dividend growth as capital requirements tighten.